Evolus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.About EOLS
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau.
CEODavid Moatazedi
CEODavid Moatazedi
Employees332
Employees332
HeadquartersNewport Beach, California
HeadquartersNewport Beach, California
Founded2012
Founded2012
Employees332
Employees332
EOLS Key Statistics
Market cap442.72M
Market cap442.72M
Price-Earnings ratio-7.46
Price-Earnings ratio-7.46
Dividend yield—
Dividend yield—
Average volume1.03M
Average volume1.03M
High today$6.83
High today$6.83
Low today$6.69
Low today$6.69
Open price$6.72
Open price$6.72
Volume534.00K
Volume534.00K
52 Week high$17.12
52 Week high$17.12
52 Week low$5.71
52 Week low$5.71
Stock Snapshot
Evolus(EOLS) stock is priced at $6.81, giving the company a market capitalization of 442.72M. It carries a P/E multiple of -7.46.
On 2025-12-04, Evolus(EOLS) stock traded between a low of $6.69 and a high of $6.83. Shares are currently priced at $6.81, which is +1.8% above the low and -0.3% below the high.
The Evolus(EOLS)'s current trading volume is 534K, compared to an average daily volume of 1.03M.
In the last year, Evolus(EOLS) shares hit a 52-week high of $17.12 and a 52-week low of $5.71.
In the last year, Evolus(EOLS) shares hit a 52-week high of $17.12 and a 52-week low of $5.71.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.